| Year |
Citation |
Score |
| 2020 |
Cracolici V, Ritterhouse LL, Segal JP, Puranik R, Wanjari P, Kadri S, Parilla M, Cipriani NA. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas. The American Journal of Surgical Pathology. PMID 32282345 DOI: 10.1097/Pas.0000000000001489 |
0.327 |
|
| 2019 |
Ritterhouse LL, Parilla M, Zhen CJ, Wurst MN, Puranik R, Henderson CM, Joudeh NZ, Hartley MJ, Haridas R, Wanjari P, Furtado LV, Kadri S, Segal JP. Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing. Molecular Diagnosis & Therapy. PMID 31673932 DOI: 10.1007/S40291-019-00436-8 |
0.322 |
|
| 2019 |
Balagopal V, Hantel A, Kadri S, Steinhardt G, Zhen CJ, Kang W, Wanjari P, Ritterhouse LL, Stock W, Segal JP. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing. Plos One. 14: e0224097. PMID 31658273 DOI: 10.1371/Journal.Pone.0224097 |
0.34 |
|
| 2019 |
Choudhury NJ, Eghtesad M, Kadri S, Cursio J, Ritterhouse L, Segal J, Husain A, Patel JD. Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center. Oncotarget. 10: 5817-5823. PMID 31645901 DOI: 10.18632/Oncotarget.27212 |
0.314 |
|
| 2019 |
Chapel DB, Patil SA, Plagov A, Puranik R, Mendybaeva A, Steinhardt G, Wanjari P, Lastra RR, Kadri S, Segal JP, Ritterhouse LL. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31186530 DOI: 10.1038/S41379-019-0298-5 |
0.332 |
|
| 2019 |
Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, et al. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Human Pathology. PMID 31054900 DOI: 10.1016/J.Humpath.2019.04.013 |
0.322 |
|
| 2019 |
Parilla M, Alikhan M, Al-Kawaaz M, Patil S, Kadri S, Ritterhouse LL, Segal J, Fitzpatrick C, Antic T. Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma. The American Journal of Surgical Pathology. PMID 30986793 DOI: 10.1097/Pas.0000000000001255 |
0.325 |
|
| 2019 |
Parilla M, Kadri S, Patil SA, Fitzpatrick C, Ritterhouse L, Segal J, Collins J, Pytel P. Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. Journal of Neuropathology and Experimental Neurology. PMID 30698790 DOI: 10.1093/Jnen/Nly130 |
0.358 |
|
| 2018 |
Cracolici V, Kadri S, Ritterhouse LL, Segal JP, Wanjari P, Cipriani NA. Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis. The American Journal of Surgical Pathology. PMID 30557173 DOI: 10.1097/Pas.0000000000001208 |
0.323 |
|
| 2018 |
Patil SA, Mujacic I, Ritterhouse LL, Segal JP, Kadri S. insiM: in silico Mutator software for bioinformatics pipeline validation of clinical next-generation sequencing (NGS) assays. The Journal of Molecular Diagnostics : Jmd. PMID 30273779 DOI: 10.1016/J.Jmoldx.2018.08.001 |
0.335 |
|
| 2018 |
Corean J, Furtado LV, Kadri S, Segal JP, Emerson LL. Cribriform-Morular Variant of Papillary Thyroid Carcinoma with Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis. International Journal of Surgical Pathology. 1066896918796946. PMID 30176755 DOI: 10.1177/1066896918796946 |
0.339 |
|
| 2018 |
Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, ... ... Kadri S, et al. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785204. PMID 30113886 DOI: 10.1200/Jco.2018.78.5204 |
0.31 |
|
| 2018 |
Parilla M, Kadri S, Patil SA, Ritterhouse L, Segal J, Henriksen KJ, Antic T. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? The American Journal of Surgical Pathology. PMID 29668487 DOI: 10.1097/Pas.0000000000001067 |
0.352 |
|
| 2018 |
Drazer MW, Kadri S, Sukhanova M, Patil SA, West AH, Feurstein S, Calderon DA, Jones MF, Weipert CM, Daugherty CK, Ceballos-López AA, Raca G, Lingen MW, Li Z, Segal JP, et al. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Advances. 2: 146-150. PMID 29365323 DOI: 10.1182/Bloodadvances.2017013037 |
0.328 |
|
| 2018 |
Parilla M, Alikhan M, Segal J, Kadri S, Fitzpatrick CM, Antic T. TCEB1-mutated renal cell carcinoma in relation to renal cell carcinoma with smooth muscle stroma in tuberous sclerosis complex. Journal of Clinical Oncology. 36: 699-699. DOI: 10.1200/Jco.2018.36.6_Suppl.699 |
0.345 |
|
| 2017 |
Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, et al. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Advances. 1: 715-727. PMID 29296715 DOI: 10.1182/Bloodadvances.2016003632 |
0.361 |
|
| 2017 |
Afik S, Bartok O, Artyomov MN, Shishkin AA, Kadri S, Hanan M, Zhu X, Garber M, Kadener S. Defining the 5΄ and 3΄ landscape of the Drosophila transcriptome with Exo-seq and RNaseH-seq. Nucleic Acids Research. PMID 28335028 DOI: 10.1093/Nar/Gkx133 |
0.302 |
|
| 2017 |
Wang YL, Ming M, Xie B, Sukhanova M, Wang W, Kadri S, Sharma S, Lee J, Shacham S, Landesman Y, Maltsev N, Lu P. XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB Blood. 130: 3837-3837. DOI: 10.1182/Blood.V130.Suppl_1.3837.3837 |
0.319 |
|
| 2017 |
Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang L, Michelson G, Curnutte JT, Conley PB. Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B Cell Malignancies: Results from a Phase I Dose Escalation Study Blood. 130: 2782-2782. DOI: 10.1182/Blood.V130.Suppl_1.2782.2782 |
0.327 |
|
| 2016 |
Yap KL, Furtado LV, Kiyotani K, Curran E, Stock W, McNeer JL, Kadri S, Segal JP, Nakamura Y, Le Beau MM, Gurbuxani S, Raca G. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & Lymphoma. 1-9. PMID 27855558 DOI: 10.1080/10428194.2016.1219902 |
0.308 |
|
| 2016 |
Kadri S, Long BC, Mujacic I, Zhen CJ, Wurst MN, Sharma S, McDonald N, Niu N, Benhamed S, Tuteja J, Seiwert T, White K, McNerney ME, Fitzpatrick C, Wang YL, et al. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. The Journal of Molecular Diagnostics : Jmd. PMID 27836695 DOI: 10.1016/J.Jmoldx.2016.07.012 |
0.318 |
|
| 2016 |
Sharma S, Galanina N, Guo A, Lee J, Kadri S, Van Slambrouck C, Long B, Wang W, Ming M, Furtado LV, Segal JP, Stock W, Venkataraman G, Tang WJ, Lu P, et al. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget. PMID 27626698 DOI: 10.18632/Oncotarget.11932 |
0.314 |
|
| 2016 |
Lan TT, Keller-Ramey J, Fitzpatrick C, Kadri S, Taxy JB, Segal JP, Furtado LV, Antic T. Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block. Virchows Archiv : An International Journal of Pathology. PMID 27173781 DOI: 10.1007/S00428-016-1952-7 |
0.344 |
|
| 2016 |
Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Theissen M, Ming M, Kobzev Y, Wenjun K, Guo A, Wang WV, Niu N, et al. Clonal Evolution Pattern of Leukemia Progression and Richter Transformation in Ibrutinib-Relapsed CLL Patients Blood. 128: 3961-3961. DOI: 10.1182/Blood.V128.22.3961.3961 |
0.371 |
|
| 2016 |
Coffey GP, Feng J, Kadri S, Wang YL, Lu P, Sharma S, Segal J, Michelson G, Pandey A, Curnutte JT, Conley PB. Genetic or CD40L-Mediated Loss of Iκbα Is Associated with Resistance to the Dual SYK/JAK Inhibitor Cerdulatinib in DLBCL Cell Lines Blood. 128: 2768-2768. DOI: 10.1182/Blood.V128.22.2768.2768 |
0.305 |
|
| 2015 |
Kadri S, Zhen CJ, Wurst MN, Long BC, Jiang ZF, Wang YL, Furtado LV, Segal JP. Amplicon Indel Hunter: A Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data. The Journal of Molecular Diagnostics : Jmd. PMID 26319364 DOI: 10.1016/J.Jmoldx.2015.06.005 |
0.334 |
|
| 2014 |
Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, ... ... Kadri S, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 157: 580-94. PMID 24726434 DOI: 10.1016/J.Cell.2014.02.030 |
0.305 |
|
| 2011 |
Kadri S, Hinman VF, Benos PV. RNA deep sequencing reveals differential microRNA expression during development of sea urchin and sea star. Plos One. 6: e29217. PMID 22216218 DOI: 10.1371/Journal.Pone.0029217 |
0.593 |
|
| 2009 |
Kadri S, Hinman V, Benos PV. HHMMiR: efficient de novo prediction of microRNAs using hierarchical hidden Markov models. Bmc Bioinformatics. 10: S35. PMID 19208136 DOI: 10.1186/1471-2105-10-S1-S35 |
0.595 |
|
| Show low-probability matches. |